Testimony: FDA Commissioner says FDA has limited authority over compounding pharmacies to prevent meningitis outbreak

During a four-hour hearing Nov. 14 led by the chairman of the House Energy and Commerce oversight subcommittee, FDA Commissioner Margaret Hamburg was asked if the FDA could have prevented the recent fungal meningitis outbreak.